Darren W. McDew - 26 Apr 2024 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship: Director
Issuer ticker: ABT
Reported as of: 26 Apr 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Apr 2024, 18:00:43 UTC
Prior SEC filing: 18 Apr 2024
Next SEC filing: 08 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Darren W. McDew by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Darren W. McDew filed Form 4 for ABBOTT LABORATORIES (ABT) on 30 Apr 2024.

Key facts

This page summarizes Darren W. McDew's Form 4 filing for ABBOTT LABORATORIES (ABT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Apr 2024, 18:00.

Change

Previous filing in this sequence was filed on 18 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Award

Transaction value: $0
Shares: +1,866
Change %: +27%
Price: $0.000000
Shares after: 8,757
Date: 26 Apr 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).